摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(d3-methyl)-5-(1,4,5,6-tetrahydropyrimidin-5-yl)-1,2,4-oxadiazole hydrochloride | 1243306-74-2

中文名称
——
中文别名
——
英文名称
3-(d3-methyl)-5-(1,4,5,6-tetrahydropyrimidin-5-yl)-1,2,4-oxadiazole hydrochloride
英文别名
——
3-(d3-methyl)-5-(1,4,5,6-tetrahydropyrimidin-5-yl)-1,2,4-oxadiazole hydrochloride化学式
CAS
1243306-74-2
化学式
C7H10N4O*ClH
mdl
——
分子量
205.62
InChiKey
WJJATTRDPBZZDJ-NIIDSAIPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.51
  • 重原子数:
    13.0
  • 可旋转键数:
    2.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    63.31
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING<br/>[FR] COMPOSÉS ET COMPOSITIONS POUR AMÉLIORER LA FONCTION COGNITIVE, PROCÉDÉS DE FABRICATION ET MÉTHODES DE TRAITEMENT
    申请人:MITHRIDION INC
    公开号:WO2010102218A1
    公开(公告)日:2010-09-10
    Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.
    提供了用于刺激肌气受体并治疗认知障碍的肌气受体激动剂。还提供了合成这类激动剂的方法。还提供了用于增强人类等受试者认知功能的组合物,该组合物包括肌气受体激动剂或其药用适宜形式。还提供了通过给予这类组合物来治疗动物如人类的方法。
  • [EN] COGNITION ENHANCING COMPOUNDS AND COMPOSITIONS, METHODS OF MAKING, AND METHODS OF TREATING<br/>[FR] COMPOSÉS ET COMPOSITIONS AMÉLIORANT LA COGNITION, MÉTHODES DE PRÉPARATION ET MÉTHODES DE TRAITEMENT
    申请人:MITHRIDION INC
    公开号:WO2012033956A1
    公开(公告)日:2012-03-15
    The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine, receptors and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans. The compositions comprising a muscarinic agonist or a pharma.ceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.
    该发明通常涉及对可用于刺激肌碱受体和治疗认知障碍的肌碱激动剂。本文披露的肌碱激动剂包括噁唑二唑衍生物组合物及其制剂。还提供了合成噁唑二唑化合物的方法。本公开还涉及部分用于增强诸如人类等受试者认知功能的组合物。该组合物包括肌碱激动剂或其药学适宜形式。本公开还涉及通过给予这种组合物来治疗动物如人类的方法。
查看更多